Sudeep Pharma

Not Rated
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0QPI01025
  • NSEID: SUDEEPPHRM
  • BSEID: 544619
INR
669.00
-1.25 (-0.19%)
BSENSE

Dec 05

BSE+NSE Vol: 7.42 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 3.77% vs -14.91% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -0.07% vs 48.94% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 54.64% vs -23.90% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -2.38% vs 46.01% in Mar 2024

Compare Profit and Loss Results of Sudeep Pharma
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
356.00
2,139.00
-1,783.00
-83.36%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
356.00
2,139.00
-1,783.00
-83.36%
Expenditure (Ex Depriciation)
Stock Adjustments
-20.00
-27.00
7.00
25.93%
Raw Materials Consumed
146.00
1,110.00
-964.00
-86.85%
Power & Fuel Cost
7.00
35.00
-28.00
-80.00%
Employee Cost
26.00
377.00
-351.00
-93.10%
Operating Expenses
14.00
132.00
-118.00
-89.39%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
26.00
98.00
-72.00
-73.47%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
5.00
0.00
5.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
223.00
1,876.00
-1,653.00
-88.11%
Operating Profit (PBDIT) excl Other Income
132.00
262.00
-130.00
-49.62%
Other Income
8.00
46.00
-38.00
-82.61%
Operating Profit (PBDIT)
141.00
308.00
-167.00
-54.22%
Interest
5.00
145.00
-140.00
-96.55%
Profit before Depriciation and Tax
135.00
162.00
-27.00
-16.67%
Depreciation
6.00
84.00
-78.00
-92.86%
Profit Before Taxation & Exceptional Items
129.00
78.00
51.00
65.38%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
129.00
78.00
51.00
65.38%
Provision for Tax
33.00
18.00
15.00
83.33%
Profit After Tax
95.00
59.00
36.00
61.02%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
321.00
719.00
-398.00
-55.35%
Profit Available for appropriations
416.00
778.00
-362.00
-46.53%
Appropriations
416.00
778.00
-362.00
-46.53%
Equity Dividend (%)
0%
40%
-40.00
Earnings Per Share
8.82
313.68
-304.86
-97.19%
Profit And Loss - Net Sales
Net Sales 356.73 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 3.77% vs -14.91% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 132.83 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -0.07% vs 48.94% in Mar 2024

Profit And Loss - Interest
Interest 5.68 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 54.64% vs -23.90% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 95.75 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -2.38% vs 46.01% in Mar 2024